Medical device manufacturer BioMet Inc. has reported that it will close a facility in Switzerland due to declining sales of its medical devices. The company recently released its BioMet M2a Magnum metal-on-metal hip replacement, which has come under fire for being linked to severe complications.
BioMet said it is considering selling after profits declined and patients began raising complaints related to the M2a Magnum. Many patients who received the metal hip implant have said they required revision surgery to fix severe complications caused by the device.
M2a Magnum side effects have been reported across the globe, with some of the most common being tissue damage, pain, fretting and corrosion. Many companies with similar metal-on-metal hip replacements have recalled their devices, though BioMet has yet to issue an M2a Magnum recall.